Literature DB >> 7246541

Autosomal recessive inheritance of human mitochondrial carbamyl phosphate synthetase deficiency.

J W McReynolds, B Crowley, M J Mahoney, L E Rosenberg.   

Abstract

The mode of inheritance of hepatic mitochondrial carbamyl phosphate synthetase (CPS I) deficiency has not been established conclusively in the past. In this study, hepatic tissue obtained by percutaneous biopsy from all members of the immediate family of two girls affected with partial CPS I deficiency was assayed for CPS I, ornithine transcarbamylase (OTC), and arginase activities. Only values for CPS I activity differed significantly from those in controls. The two affected girls each had markedly reduced CPS I activities of about 6% of the control mean. Their brother had activity well within the normal range. Of greatest significance was the finding that both parents had activities below the 95% confidence limits in controls, and intermediate between the deficient values of the two girls and the control range. The father and mother had, respectively, 32% and 54% of mean control activity. These data indicate that CPS I deficiency is inherited as an autosomal recessive trait and that the two affected girls are homozygous for the mutant gene, their brother is homozygous for the normal allele, and the parents are heterozygous.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7246541      PMCID: PMC1685048     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  23 in total

1.  Massive pulmonary hemorrhage as a presenting feature in congenital hyperammonemia.

Authors:  L J Sheffield; D M Danks; J W Hammond; N J Hoogenraad
Journal:  J Pediatr       Date:  1976-03       Impact factor: 4.406

2.  Treatment of carbamyl phosphate synthetase deficiency with keto analogues of essential amino acids.

Authors:  M Batshaw; S Brusilow; M Walser
Journal:  N Engl J Med       Date:  1975-05-22       Impact factor: 91.245

3.  Hyperornithinemia, hyperammonemia, and homocitrullinuria associated with decreased carbamyl phosphate synthetase I activity.

Authors:  P D Gatfield; E Taller; D M Wolfe; M D Haust
Journal:  Pediatr Res       Date:  1975-05       Impact factor: 3.756

4.  [Constitutional hyperammonemia with carbamoylphosphate synthetase deficiency. Course treatment during dietetic].

Authors:  M Odievre; C Charpentier; L Cathelineau; J Vedrenne; F Delacoux des Roseaux; C Mercie
Journal:  Arch Fr Pediatr       Date:  1973-01

5.  Lethal neonatal deficiency of carbamyl phosphate synthetase.

Authors:  T D Gelehrter; P J Snodgrass
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

6.  Evidence for x-linked dominant inheritance of ornithine transcarbamylase deficiency.

Authors:  E M Short; H O Conn; P J Snodgrass; A G Campbell; L E Rosenberg
Journal:  N Engl J Med       Date:  1973-01-04       Impact factor: 91.245

7.  A case of carbamyl phosphate synthetase deficiency.

Authors:  S Arashima; I Matsuda
Journal:  Tohoku J Exp Med       Date:  1972-06       Impact factor: 1.848

8.  Carbamylphosphate synthetase deficiency in an infant with severe cerebral damage.

Authors:  F A Hommes; C J De Groot; C W Wilmink; J H Jonxis
Journal:  Arch Dis Child       Date:  1969-12       Impact factor: 3.791

9.  Letter: Reye's syndrome.

Authors:  T Brown; G Hug; K Bove; H Brown; L Lansky
Journal:  Lancet       Date:  1974-09-21       Impact factor: 79.321

10.  Abnormalities of carbamyl phosphate synthetase and ornithine transcarbamylase in liver of patients with Reye's syndrome.

Authors:  F Sinatra; T Yoshida; M Applebaum; N J Masion Hoogenraad; P Sunshine
Journal:  Pediatr Res       Date:  1975-11       Impact factor: 3.756

View more
  8 in total

1.  Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes.

Authors:  Dashuang Shi; Gengxiang Zhao; Nicholas Ah Mew; Mendel Tuchman
Journal:  Mol Genet Metab       Date:  2016-12-08       Impact factor: 4.797

2.  Carbamyl phosphate synthetase deficiency with lethal neonatal outcome.

Authors:  J Jaeken; H Devlieger; C Bachmann; J Van Aerde; L Corbeel; E Eggermont
Journal:  Eur J Pediatr       Date:  1982-09       Impact factor: 3.183

Review 3.  CPS1: Looking at an ancient enzyme in a modern light.

Authors:  Matthew Nitzahn; Gerald S Lipshutz
Journal:  Mol Genet Metab       Date:  2020-10-10       Impact factor: 4.797

4.  Molecular genetic research into carbamoyl-phosphate synthase I: molecular defects and linkage markers.

Authors:  M L Summar
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

5.  Genetic analysis of carbamyl phosphate synthetase I deficiency.

Authors:  E R Fearon; R L Mallonee; J A Phillips; W E O'Brien; S W Brusilow; M W Adcock; L T Kirby
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

Review 6.  Contrasting features of urea cycle disorders in human patients and knockout mouse models.

Authors:  Joshua L Deignan; Stephen D Cederbaum; Wayne W Grody
Journal:  Mol Genet Metab       Date:  2007-10-22       Impact factor: 4.797

Review 7.  Hypertension genomics and cardiovascular prevention.

Authors:  Fu Liang Ng; Helen R Warren; Mark J Caulfield
Journal:  Ann Transl Med       Date:  2018-08

8.  Effects of a high protein diet and liver disease in an in silico model of human ammonia metabolism.

Authors:  Jeddidiah W D Griffin; Patrick C Bradshaw
Journal:  Theor Biol Med Model       Date:  2019-07-31       Impact factor: 2.432

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.